A US appeals court froze federal rules allowing access to medication abortion via telehealth, siding with Louisiana’s attorney general.
Louisiana Challenges Federal Abortion Access Rules
The Fifth Circuit Court of Appeals (Mississippi, Louisiana, and Texas) ruled in favor of Louisiana’s attorney general, effectively halting federal regulations implemented during the Joe Biden administration. These regulations had enabled telehealth consultations and mail delivery of abortion pills.
Louisiana argued that easing access to mifepristone undermined state laws protecting unborn life and forced the state to bear the costs of emergency medical care for women harmed by the drug. A lower court had previously allowed remote prescription of mifepristone, a decision now temporarily blocked.
Medication Abortion Dominates US Procedures
Medication abortions using this drug now account for over 60% of all abortion procedures in the US healthcare system. Following the 2022 Supreme Court ruling that eliminated federal guarantees of abortion rights, telehealth and mail delivery became crucial access points in states with bans or severe restrictions.
Anti-Abortion Groups Celebrate the Ruling
The appeals court decision was hailed as a victory by anti-abortion groups, who had pressured the Donald Trump administration to reinstate the requirement for in-person dispensing of mifepristone.
Political Reactions and “Abortion Cartel” Accusations
Louisiana Attorney General Liz Murrill declared a “victory for life,” and accused the Biden administration of running an “abortion cartel” that had facilitated the deaths of thousands of children through illegal mail delivery of abortion pills.
Pro-Choice Organizations Condemn “Political Blockade”
Pro-choice organizations denounced the decision as a politically motivated attempt to restrict abortion access. Nancy Northup, head of the Center for Reproductive Rights, argued it wasn’t about science but about making abortion “difficult, costly, and inaccessible.”
Regina Davis Moss of In Our Own Voice emphasized that reinstating the in-person dispensing requirement would create financial burdens for many women, especially during times of economic hardship.
Supreme Court Appeal Expected
Danco Laboratories, one of the companies distributing mifepristone in the US, announced it would file an emergency appeal to the Supreme Court. The dispute over access to the abortion pill is likely to return to the highest court.
The Supreme Court previously granted states the right to independently establish abortion regulations in 2022. Since then, around 20 states have banned abortion or significantly tightened restrictions, with Louisiana’s laws among the most restrictive.
